NEWS
All News
Special Reports
CONFERENCES
Conference Coverage
Conference Listing
MEDIA
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
PUBLICATIONS
All Publications
Evolving Paradigms
Roundtable Meetings Spotlight
Targeted Therapies in Oncology
CME/CE
RESOURCES
Case-Based Roundtable Series
Clinical Trials
Partners
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
SUBSCRIBE
eNewsletter

logo
Featured Clinical Focus
AML
BTK Inhibitors: In-Focus
Biomarker-Driven Lung Cancer
Bone Marrow & SCT
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR-Positive Lung Cancer
Endometrial Cancer
Follicular Lymphoma
HCC
Lung Cancer
MPNs
Mantle Cell Lymphoma
Multiple Myeloma
Renal Cell Carcinoma
Small Cell Lung Cancer
Thyroid Cancers
Clinical Focus
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
Spotlight
Case Based Peer Perspectives
Case-Based Roundtable Series
Clinical Trials
Podcasts
Precision Medicine
Special Reports
All News
Special Reports
Conference Coverage
Conference Listing
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
All Publications
Evolving Paradigms
Roundtable Meetings Spotlight
Targeted Therapies in Oncology
CME/CE
Case-Based Roundtable Series
Clinical Trials
Partners
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
eNewsletter
Advertisement
BIOMARKER-DRIVEN LUNG CANCER
| BONE MARROW & STEM CELL TRANSPLANT
| GYNECOLOGIC CANCERS
| HEMATOLOGY
| LUNG CANCER
| SMALL CELL LUNG CANCER
| THYROID CANCERS
| BRAIN CANCER
| BREAST CANCER
| CAR T-CELL THERAPY
| ENDOMETRIAL CANCER
| GASTRIC CANCER
| GENITOURINARY CANCERS
| GENOMIC TESTING
| GI CANCERS
| HCC
| HEAD & NECK CANCERS
| IMMUNOTHERAPY
| LEUKEMIAS
| LYMPHOMAS
| MET-TARGETED THERAPY
| NTRK GENE FUSIONS
| SARCOMA
| SKIN CANCERS
View All >>
  • BIOMARKER-DRIVEN LUNG CANCER
  • BONE MARROW & STEM CELL TRANSPLANT
  • BRAIN CANCER
  • BREAST CANCER
  • CAR T-CELL THERAPY
  • ENDOMETRIAL CANCER
  • GASTRIC CANCER
  • GENITOURINARY CANCERS
  • GENOMIC TESTING
  • GI CANCERS
  • GYNECOLOGIC CANCERS
  • HCC
  • HEAD & NECK CANCERS
  • HEMATOLOGY
  • IMMUNOTHERAPY
  • LEUKEMIAS
  • LUNG CANCER
  • LYMPHOMAS
  • MET-TARGETED THERAPY
  • NTRK GENE FUSIONS
  • SARCOMA
  • SKIN CANCERS
  • SMALL CELL LUNG CANCER
  • THYROID CANCERS

SPOTLIGHT -

Case Based Peer Perspectives
| Case-Based Roundtable Series
| Clinical Trials
| Podcasts
| Precision Medicine
| Special Reports

BCR-ABL1 TKIs in Relapsed/Refractory CML

home / precision-medicine / relapsed-refractory-cml

Chronic Myeloid Leukemia


CML as an Ideal Cancer for Targeted Therapy With TKI

EP. 1: CML as an Ideal Cancer for Targeted Therapy With TKI

June 24th 2019

Watch


BCR-ABL1-Targeted TKIs in Treatment of CML

EP. 2: BCR-ABL1-Targeted TKIs in Treatment of CML

June 24th 2019

Watch


Response Monitoring of Patients With CML Treated With TKIs

EP. 3: Response Monitoring of Patients With CML Treated With TKIs

June 24th 2019

Watch


Importance of Compliance With TKIs in Treatment of CML

EP. 4: Importance of Compliance With TKIs in Treatment of CML

June 24th 2019

Watch


Resistance to Targeted-TKI Treatment in Patients With CML

EP. 5: Resistance to Targeted-TKI Treatment in Patients With CML

June 24th 2019

Watch


Frontline Treatment for CML With BCR-ABL-Targeted TKIs

EP. 6: Frontline Treatment for CML With BCR-ABL-Targeted TKIs

June 24th 2019

Watch


Role of Ponatinib in Treatment of R/R CML

EP. 7: Role of Ponatinib in Treatment of R/R CML

June 24th 2019

Watch


Early Intervention With Ponatinib in Treatment of CML

EP. 8: Early Intervention With Ponatinib in Treatment of CML

June 24th 2019

Watch


Bosutinib Versus Ponatinib in R/R CML

EP. 9: Bosutinib Versus Ponatinib in R/R CML

June 24th 2019

Watch


Adverse Events of Second-Generation TKIs Used in Treating CML

EP. 10: Adverse Events of Second-Generation TKIs Used in Treating CML

June 24th 2019

Watch


Dose-Related Adverse Events With Ponatinib When Treating CML

EP. 11: Dose-Related Adverse Events With Ponatinib When Treating CML

June 24th 2019

Watch


Treatment-Free Remission & Toxicities of Discontinuing CML Therapy

EP. 12: Treatment-Free Remission & Toxicities of Discontinuing CML Therapy

June 24th 2019

Watch


Challenges in Management of Chronic Phase CML

EP. 13: Challenges in Management of Chronic Phase CML

June 24th 2019

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.